These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2612495)

  • 21. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2000; (3):CD001909. PubMed ID: 10908514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2001; (3):CD001909. PubMed ID: 11687001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human safety of lamotrigine.
    Betts T; Goodwin G; Withers RM; Yuen AW
    Epilepsia; 1991; 32 Suppl 2():S17-21. PubMed ID: 1837776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the clinical efficacy of lamotrigine.
    Richens A; Yuen AW
    Epilepsia; 1991; 32 Suppl 2():S13-6. PubMed ID: 1837775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.
    Besag FM; Dulac O; Alving J; Mullens EL
    Seizure; 1997 Feb; 6(1):51-6. PubMed ID: 9061824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old.
    Piña-Garza JE; Elterman RD; Ayala R; Corral M; Mikati MA; Piña-Garza MJ; Warnock CR; Conklin HS; Messenheimer JA
    J Child Neurol; 2008 Aug; 23(8):853-61. PubMed ID: 18660469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
    Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
    Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
    Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
    Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.
    Sander JW; Trevisol-Bittencourt PC; Hart YM; Patsalos PN; Shorvon SD
    Epilepsy Res; 1990 Dec; 7(3):226-9. PubMed ID: 2289481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo multifocal myoclonus induced by lamotrigine in a temporal lobe epilepsy case.
    Tombini M; Pellegrino G; Assenza G; Di Lazzaro V
    J Neurol Sci; 2017 Feb; 373():31-32. PubMed ID: 28131212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.